Nalu Bio

About:

Nalu Bio is a biotechnology company that focuses on a science and data-driven approach to cannabanoid biology.

Top Investors: Newchip Accelerator, Golden Seeds, Portfolia, Flybridge, XFactor Ventures

Description:

Nalu Bio is a biotech company developing CBD (and cannabinoids) through chemistry (not plants), for companies who want pure and safe ingredients that are better for the planet. Ranked as the #1 CBD producer on the “google for ingredients.” Like plant-based meats, Nalu Bio will fundamentally disrupt CBD production with chemistry. Nalu Bio uses 700x less land, 70x less water, and 14x less energy to produce its cannabinoids while ensuring best-in-class purity and quality (0% THC, no chemicals, no pesticides) without the high capital investment costs of hemp extraction and biosynthesis.

Total Funding Amount:

$12.3M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Francisco, California, United States

Founded Date:

2019-01-01

Founders:

Caitlyn Krebs, Phyllis Whiteley, Randall Ussery

Number of Employees:

11-50

Last Funding Date:

2023-02-28

IPO Status:

Private

Industries: